Rosemont Pharmaceuticals
Generated by Meeveem AI
"A specialty pharmaceutical leader in oral liquid medicines for patients with swallowing difficulties"
About Rosemont Pharmaceuticals
Rosemont Pharmaceuticals develops, manufactures and supplies oral liquid medicines for patients with swallowing difficulties. Established in 1967 by two pharmacists, it has a portfolio of more than 130 oral liquid medicines, including over 70 UK licensed products. The business produces over four million bottles annually and exports to more than 40 countries.
Headquartered in Leeds, Rosemont has UK manufacturing, research and development facilities in the UK and Greece, and commercial offices and logistics in the US. It advocates licensed oral liquid medicines as an alternative to manipulating solid doses, such as crushing tablets. Its educational materials help healthcare professionals understand medication management challenges for patients with dysphagia.
Quality and manufacturing
Rosemont’s manufacturing work follows Good Manufacturing Practice and ICH Q10 quality guidelines. Its facilities are inspected by UK and US pharmaceutical regulators, with additional inspections by healthcare institutions and customers purchasing its medicines.
Support for employees
Rosemont is a Living Wage Employer. Its published employee benefits cover family leave, financial wellbeing and health support, including a healthcare cash plan and an employee assistance programme. Its Rosemont & You calendar recognises employee milestones and events reflecting the workforce’s different backgrounds.
290
Team Members
1967
Founded
Pharma
Sector
Hybrid
Work Environment